- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02538276
Carotid Endarterectomy and Carotid Artery Stenting in Brazil
Study of a Real-word Registry of Carotid Endarterectomy and Carotid Artery Stenting in Brazil. Analysis of Prospective Cases of the Registry of Vascular Diseases at University Hospitals of the State of São Paulo
Study Overview
Status
Conditions
Detailed Description
This study will be a prospective analysis of the treatment of patients with carotid stenosis through carotid endarterectomy and carotid artery stenting performed at 5 centers proposed by five years with the Vascular Study Group from public Universities of Sao Paulo state in Brazil. The primary outcome measures will be:
- any in-hospital stroke.
- any stroke, death, or myocardial infarction (MI). Patients undergoing CEA in conjunction with cardiac surgery will be excluded. Multivariate logistic regression will be performed to identify predictors of stroke or death in patients undergoing CEA and CAS.
The characteristics and background of patients who underwent CAS and CEA include: age, gender, carotid endarterectomy high risk; also presentation of symptoms, and degree of stenosis will be analyzed. Next, procedural success, periprocedural antiplatelet use, embolic protection device use, the type of stent (open-cell or closed-cell) or patch to carotid, the execution of pre ballooning or post ballooning dilatation at carotid artery stenting, and procedure-related complications will be analyzed to clarify the current strategy and the treatment results of both techniques . Degree of stenosis have been measured in accordance with North American Symptomatic Carotid Endarterectomy Trial method.
Outcomes will be stratified by symptomatic and asymptomatic status. Symptomatic patients are defined as having a neurologic event, including any hemispheric or ocular transient ischemic attack,major or minor stroke preceding the intervention ipsilateral to the treated lesion. Technical success relates to periprocedural events that occur from the initiation of the procedure and extend through the first 24-hour postoperative period. Primary technical success was defined on an intent-to-treat basis, and it will requires the successful exclusion of the carotid plaque by surgical or interventional means. Technical success include the outcomes and complications of preoperative carotid angiograms whenever these imaging studies are obtained prior to the carotid intervention. For carotid endarterectomy, primary technical success implies a successful removal of the carotid plaque and closure of the artery with or without patch and less than a 30% residual stenosis. For carotid stenting, the introduction and deployment of the embolic protection device and the carotid stent in the absence of stroke, myocardial infarction, death, surgical conversion, or vascular obstruction constitutes primary technical success.
All complications should be categorized as local vascular, local nonvascular, and systemic. Other complications. As with any vascular procedures, complications after carotid interventions should be reported in a systematic and standardized manner with a description of the degrees of severity. Although assigning a degree of severity to all complications of different methods of treatment may be difficult, severity scales should be provided whenever possible so adverse events can be assessed and compared. The following severity scale has been modified from the reporting standards for lower extremity ischemia:Mild (1) refers to a complication that resolves spontaneously or with minimal intervention, does not increase the hospital length of stay, and does not cause permanent disability. Moderate (2) refers to the need for significant intervention, prolongation of hospitalization more than 24 hours, and at most, minor permanent disability that does not interfere with normal daily activity. A severe complication (3) needs major surgical, endovascular or medical intervention, may be associated with prolonged convalescence, is usually accompanied by prolonged or permanent disability, and may result in death.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
SP
-
Ribeirao Preto, SP, Brazil, 14090042
- Recruiting
- University Hospital of Ribeirao Preto Medical School, University of São Paulo
-
Contact:
- Edwaldo E Joviliano, MD; PhD
- Phone Number: 2406 551636021000
- Email: eejoviliano@gmail.com
-
Contact:
- Winston B Yoshida, MD; PhD
- Phone Number: 551438116269
- Email: jvascbr.ed@gmail.com
-
-
Sao Paulo
-
Botucatu, Sao Paulo, Brazil, 18607621
- Recruiting
- University Hospital of Botucatu Medical School
-
Contact:
- Winston B Yoshida, MD; PhD
- Phone Number: 551638116269
- Email: jvascbr.ed@gmail.com
-
Contact:
- Marcone L Sobreira, MD; PhD
- Phone Number: 551438116269
- Email: mlsobreira@gmail.com
-
-
São Paulo
-
Campinas, São Paulo, Brazil, 13083888
- Recruiting
- University Hospital of School of Medical Sciences UNICAMP
-
Contact:
- Ana T Guillaumon, MD; PhD
- Phone Number: 5519981849370
- Email: anaterezinha.guillaumon@gmail.com
-
Marilia, São Paulo, Brazil, 17519030
- Recruiting
- University Hospital of Marilia Medical School
-
Contact:
- Marcelo J Almeida, MD; PhD
- Phone Number: 5514996012417
- Email: mjalmeida13@gmail.com
-
Sao Jose do Rio Preto, São Paulo, Brazil, 15090000
- Recruiting
- University Hospital of São Jose do Rio Preto Medical School
-
Contact:
- Selma R Raymundo, MD; PhD
- Phone Number: 5517996016062
- Email: selma.raymundo@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with carotid stenosis > 70% who wil be underwent to carotid endarterectomy or carotid artery stenting.
Exclusion Criteria:
- Need to concomitant cardiac surgery.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Group carotid endarterectomy (CEA)
Patients submitted to carotid endarterectomy
|
Group carotid stenting (CAS)
Patients submitted to carotid artery stenting
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
any stroke
Time Frame: 30-day
|
major or minor, ipsilateral or contralateral.
Postoperative major strokes will be defined as cortical, vertebrobasilar, or ocular disability resulting in nonindependent living status, or blindness; otherwise strokes will be defined as minor
|
30-day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
any stroke, death or myocardial infarction
Time Frame: 30-day
|
major or minor, ipsilateral or contralateral for stroke, 30-day mortality and/or myocardial infarction confirmed by electrocardiogram and / or positive marker (Troponin).
|
30-day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: EDWALDO E JOVILIANO, MD; PHD, University of Sao Paulo
Publications and helpful links
General Publications
- Joviliano EE, Ribeiro MS, Sobreira ML, Moura R, Geiger MA, Guillamon AT, Regina de Oliveira Raymundo S, Miquelin DG, Hafner L, Almeida MJ, Oliveira TF, Dalio MB, Yoshida WB. Short-Term Outcomes of Transfemoral Carotid Artery Stenting and Carotid Endarterectomy in Symptomatic Patients: Data from a Multicentric Prospective Registry in Brazil. Ann Vasc Surg. 2022 Sep;85:41-48. doi: 10.1016/j.avsg.2022.04.053. Epub 2022 May 16.
- Joviliano EE, Yoshida WB, Sobreira ML, Moura R, Guillaumon AT, Raymundo SR, Miquelin DG, Hafner L, Almeida MJ. An Observational Registry of Carotid Endarterectomy and Carotid Artery Stenting in Brazil: Study Protocol. JMIR Res Protoc. 2016 Nov 23;5(4):e226. doi: 10.2196/resprot.5986.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 01/2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arterial Diseases, Carotid
-
Albert Einstein Healthcare NetworkTerminatedCarotid Stenosis | Femoral Arterial Stenosis | Carotid Bruit Asymptomatic | Carotid MurmurUnited States
-
Silk Road MedicalCompletedCarotid Artery Plaque | Carotid Stenosis | Carotid Artery Diseases | Carotid Atherosclerosis | Carotid DiseaseUnited States, Spain
-
Mayo ClinicMedical University of South Carolina; University of Maryland; University of Alabama... and other collaboratorsEnrolling by invitationStenoses, CarotidUnited States
-
Xuanwu Hospital, BeijingRecruitingCarotid Artery Plaque | Carotid Artery Stenting | Carotid EndarterectomyChina
-
Oslo University HospitalCompletedCarotid Artery Stenoses
-
Medical University of SilesiaSilesian University of MedicineUnknown
-
Prim PD Dr Afshin AssadianWilhelminenspital ViennaUnknownAtherosclerosis | Carotid Artery DiseaseAustria
-
Contego Medical, Inc.Completed
-
Sohag UniversityRecruitingCarotid Artery Plaque | Carotid Stenosis | Carotid AtherosclerosisEgypt
-
Linkoeping UniversityRegion Östergötland; Region Jönköping County; FORSS, Forskningsrådet i Sydöstra...CompletedCarotid Artery Plaque | Carotid Stenosis | Carotid Atherosclerosis